Theriva Biologics
TOVX · NYSE American
$0.208+$0.002 (+0.97%)TodayMarket closed ·
Prev close $0.206
EPS: actual vs estimate
Beat the estimate in 6 of the last 8 quarters, by 38.3% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.051 | -$0.07 | −37.3% |
| Q1 FY26 | -$0.051 | -$0.05 | +2.0% |
| Q4 FY25 | -$0.4437 | -$0.29 | +34.6% |
| Q3 FY25 | -$0.7701 | -$0.45 | +41.6% |
| Q2 FY25 | -$0.9333 | -$0.57 | +38.9% |
| Q1 FY25 | -$4.27 | -$1.55 | +63.7% |
| Q4 FY24 | -$6.49 | -$3.30 | +49.1% |
| Q3 FY24 | -$6.38 | -$6.81 | −6.8% |
Earnings calls
- Special Call - Theriva Biologics, Inc.
- 2023 Earnings Call
- TOVX - Earnings call 3 2023
- Special Call - Theriva Biologics, Inc.
- TOVX - Earnings call Q2 2023
- Earnings call Q2 2023
- TOVX - Earnings call 1 2023
- TOVX - Earnings call 4 2022
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.